Nectar Lifesciences Limited has secured a favorable legal outcome with the Mumbai City Civil Commercial Court returning a plaint filed against the company, effectively disposing of the litigation with no liability.

Court Dismisses Suit on Jurisdictional Grounds

The Mumbai City Civil Commercial Court returned the plaint filed by Sanjay Chemicals India Private Limited on March 07, 2026, citing a lack of jurisdiction to hear the matter. The company received notification of the court's decision via email on the same date.

The plaintiff had initiated legal proceedings seeking substantial financial recovery from Nectar Lifesciences. However, the company successfully contested the suit on both jurisdictional and temporal grounds.

Financial Claims and Company's Defense

Sanjay Chemicals India Private Limited had sought recovery of significant amounts through the litigation:

Nectar Lifesciences mounted a robust defense, successfully arguing two key points that led to the favorable outcome. The company contended that the Mumbai court lacked proper jurisdiction to adjudicate the matter and that the plaintiff's claims were time-barred under applicable legal provisions.

Litigation Outcome and Financial Impact

The court's decision to return the plaint has resulted in the complete disposal of the suit with no adverse consequences for Nectar Lifesciences. The company has confirmed that there are no financial implications arising from this litigation outcome.

Regulatory Compliance

The disclosure was made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This update follows the company's previous litigation disclosure dated October 07, 2024, ensuring stakeholders remain informed of material legal developments.

The favorable resolution eliminates potential financial exposure and demonstrates the company's effective legal strategy in defending against unfounded claims.

Nectar lifesciences Limited has announced that its board of directors approved a significant inter-corporate loan facility during their meeting on March 02, 2026. The pharmaceutical company's board sanctioned an amount of up to INR 120 crores as a loan to its proposed wholly owned subsidiary, Avensis Exports Private Limited, following the completion of the acquisition process.

Board Meeting Details

The board meeting was conducted on Monday, March 02, 2026, commencing at 04:00 P.M. IST and concluding at 04:30 P.M. IST. The loan approval was part of broader decisions taken during this meeting, as referenced in the company's earlier disclosure dated March 02, 2026.

Regulatory Compliance and Disclosure

The company has committed to providing detailed disclosures regarding the loan agreement as per SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. These comprehensive disclosures will be submitted to the stock exchanges after the finalization of the definitive loan agreement with the proposed wholly owned subsidiary.

Nectar Lifesciences acknowledged an administrative oversight in the initial disclosure process, stating that the delay was inadvertent and unintentional. The company expressed regret for the omission and assured the exchanges of its commitment to furnishing all material information within prescribed time limits in the future.

Corporate Structure Development

The inter-corporate loan represents a strategic financial arrangement to support the operations of Avensis Exports Private Limited post-acquisition. The loan facility will be activated after the completion of the acquisition process, indicating the company's planned expansion of its corporate structure through the wholly owned subsidiary model.

The disclosure was made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency with stakeholders regarding this significant financial commitment. Company Secretary and Compliance Officer Sanjaymohan Singh Rawat signed the official communication to the stock exchanges on March 03, 2026.